Skip to main content
Clinical Trials/NCT06705205
NCT06705205CompletedNot Applicable

Short, Animated Storytelling Video to Reduce Addiction Stigma: Protocol for a Multi-country, Online, Randomized, Controlled Trial With 13,500 Participants

Stanford University2 sites in 1 country13,397 target enrollmentStarted: July 3, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
13,397
Locations
2
Primary Endpoint
Change in Addiction Stigma Scale Score as measured by the Attribution Questionnaire (AQ)

Study Overview

Brief Summary

Stigma towards people with addiction is a well-documented problem that negatively impacts help-seeking, treatment and recovery. Social contact with people recovering from addiction can promote empathy and reduce stigma, but social contact is difficult to scale. Short, animated storytelling (SAS) is a novel health communication approach that scales easily because it can leapfrog barriers associated with language, culture, literacy and education levels. This study will investigate if a SAS video intervention can be used to reduce stigma, boost optimism and hope, and increasing empathy towards people with addiction. The study will also explore mechanisms of action of SAS interventions, by measuring the contribution of sound design to the effect of the intervention.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 49 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Adults with basic English proficiency between the ages of 18-49

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in Addiction Stigma Scale Score as measured by the Attribution Questionnaire (AQ)

Time Frame: Immediately post-intervention on Day 1 and after two weeks

Participants complete an 18-item shortened version of the validated AQ. The AQ-18 will be scored along a 9-point Likert scale indicating the extent to which participants agree with the item ranging from "not at all" to "very much" with a maximum score of 27 for each 3-item construct. Higher scores indicate greater stigma.

Secondary Outcomes

  • Change in Optimism Scale Score(Immediately post-intervention on Day 1 and after two weeks)
  • Change in Attitude Thermometer Score(Immediately post-intervention on Day 1 and after two weeks)
  • Change in Levels of Hope using a visual analogue scale (VAS)(Immediately post-intervention on Day 1 and after two weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Maya Adam

Clinical Associate Professor of Pediatrics

Stanford University

Study Sites (2)

Loading locations...

Similar Trials